8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.19%
Positive revenue growth while 3141.T is negative. John Neff might see a notable competitive edge here.
2.25%
Positive gross profit growth while 3141.T is negative. John Neff would see a clear operational edge over the competitor.
4.51%
EBIT growth below 50% of 3141.T's 33.33%. Michael Burry would suspect deeper competitive or cost structure issues.
4.40%
Positive operating income growth while 3141.T is negative. John Neff might view this as a competitive edge in operations.
-2.80%
Negative net income growth while 3141.T stands at 44.32%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-2.81%
Negative EPS growth while 3141.T is at 44.37%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-2.81%
Negative diluted EPS growth while 3141.T is at 44.37%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
55.34%
Similar 10Y revenue/share CAGR to 3141.T's 53.35%. Walter Schloss might see both firms benefiting from the same long-term demand.
55.34%
5Y revenue/share CAGR similar to 3141.T's 53.35%. Walter Schloss might see both companies benefiting from the same mid-term trends.
55.34%
3Y revenue/share CAGR similar to 3141.T's 53.35%. Walter Schloss would assume both companies experience comparable short-term cycles.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
152.68%
Similar net income/share CAGR to 3141.T's 141.98%. Walter Schloss would see parallel tailwinds or expansions for both firms.
152.68%
5Y net income/share CAGR similar to 3141.T's 141.98%. Walter Schloss might see both on parallel mid-term trajectories.
152.68%
3Y net income/share CAGR similar to 3141.T's 141.98%. Walter Schloss would attribute it to shared growth factors or demand patterns.
82.37%
Equity/share CAGR of 82.37% while 3141.T is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
82.37%
Equity/share CAGR of 82.37% while 3141.T is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
82.37%
Equity/share CAGR of 82.37% while 3141.T is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.19%
Inventory is declining while 3141.T stands at 15.48%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-2.57%
Negative asset growth while 3141.T invests at 2.96%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
4.07%
BV/share growth above 1.5x 3141.T's 2.64%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-13.18%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.